Antifungal Drugs: The Current Armamentarium and Development of New Agents
The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Abstract
Invasive fungal infections are becoming an increasingly important cause of human mortality and morbidity, particularly for immunocompromised populations. The fungal pathogens Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus collectively contribute to over 1 million human deaths annually. Hence, the importance of safe and effective antifungal therapeutics for the practice of modern medicine has never been greater. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for drug development remains limited. Only three classes of molecules are currently approved for the treatment of invasive mycoses. The efficacy of these agents is compromised by host toxicity, fungistatic activity, or the emergence of drug resistance in pathogen populations. Here we describe our current arsenal of antifungals and highlight current strategies that are being employed to improve the therapeutic safety and efficacy of these drugs. We discuss state-of-the-art approaches to discover novel chemical matter with antifungal activity and highlight some of the most promising new targets for antifungal drug development. We feature the benefits of combination therapy as a strategy to expand our current repertoire of antifungals and discuss the antifungal combinations that have shown the greatest potential for clinical development. Despite the paucity of new classes of antifungals that have come to market in recent years, it is clear that by leveraging innovative approaches to drug discovery and cultivating collaborations between academia and industry, there is great potential to bolster the antifungal armamentarium.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tolerance can be affected by several adjuvant drugs 12 , iron levels 26 , and genes involved in vacuolar protein sorting 19 , as well as calcium flux 14,27,28 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [12]
In the citing paper
“The current arsenal of antifungal compounds used for the treatment of aspergillosis consists of three classes of antifungal agents, two of them targeting ergosterol, the functional fungal analogue of cholesterol and the major component specific to fungal membranes, and a third class that targets the synthesis of β1,3 glucan, the major component of the fungal cell wall (610–614) (Fig. 20).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [613]
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953 · cited 1×
“cerevisiae genome are essential for viability (149).”
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationThe Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162 · cited 3×
“Combination therapy also has the potential to unveil myriad additional antifungal targets given that fungal biology is controlled by a highly interconnected and functionally redundant network of biological interactions (147, 148).”
Background
Research works printed but not linked: 1
- CDC. 2013. Antibiotic Resistance Threats in the United States 2013 . CDC Atlanta GA. [PubMed]
Cited by
Items 201–300 of 319
Discovery and development of novel substituted monohydrazides as potent antifungal agents
Chandrika, N. T., Green, K. D., Spencer, A. C., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00167a · Cited by 2
Ortiz, S. C., Easter, T., Valero, C., Bromley, M., & Bertuzzi, M. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103942 · Cited by 2
8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections
Reginatto, P., Joaquim, A. R., Teixeira, M. L., de Andrade, S. F., & Fuentefría, A. M. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001952 · Cited by 2
Adam, D., Bensaada, D., Stulanovic, N., Focant, J.-F., Stefanuto, P., & Rigali, S. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02666-25 · Cited by 2
Bioinformatics in Antifungal Design: Strategies To Overcome Resistance from a Proteomic Perspective
Silva, D. R., Costa, E. M. M. D. B., Silva, J. P. R., Campos, L. T., Batista, V. M. A., de Araújo, C. V., Albino, S. L., de Farias, A. G. C., Nascimento, I. J. D. S., & de Moura, R. O. (2026) · Current Fungal Infection Reports · doi:10.1007/s12281-026-00523-4 · Cited by 2
Jiang, L., Yang, S., Li, Y., Zhang, Y., Ren, X., Liu, W. T., Fu, H., Bao, C., Qi, Q., Liu, T., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1861239 · Cited by 2
Achilonu, C. C. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5030047 · Cited by 2
Nanochitosan-Based Fish Disease Prevention and Control
Oniha, M. I., Oyesola, O. L., Taiwo, O. S., Oyejide, S. O., Akindana, S. A., Ajanaku, C. O., & Isibor, P. O. (2024) · Springer eBooks · doi:10.1007/978-3-031-52261-1_4 · Cited by 2
Kumar, M., Kajal, K., Taranum, N., Khyati, Balan, B., Kumar, P., & Dhaulaniya, A. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_22 · Cited by 2
Pharmacokinetics and Pharmacodynamics of Antifungal Agents in Neonates and Children
Antachopoulos, C., & Roilides, E. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00402-6 · Cited by 2
Luberto, L., Neroni, B., Gandini, O., Fiscarelli, E. V., Salvatori, G., Roscilli, G., & Marra, E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.789774 · Cited by 2
Structural Insights into Selectively Targeting Candida albicans Hsp90
Kowalewski, M. E., Zagler, S. G., & Redinbo, M. R. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00015 · Cited by 2
Fungal immunization potentiates CD4+ T cell-independent cDC2 responses for cross-presentation
Kulkarni, N. A., & Nanjappa, S. G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602174 · Cited by 2
Rocha, M. C., Santos, C. A., & Malavazi, I. (2018) · Current Proteomics · doi:10.2174/1570164615666180820155807 · Cited by 2
Tuo, Y., Li, G., Liu, Z., Yu, N. H., Li, Y., Li, Y., Liu, H., & Wang, Y. (2022) · New Journal of Chemistry · doi:10.1039/d1nj04927e · Cited by 2
Drugs for the Treatment of Fungal Infections
Seifert, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-18899-3_35 · Cited by 2
DeJarnette, C. A. (2020) · doi:10.21007/etd.cghs.2020.0518 · Cited by 2
Emergência da infeção fúngica nas unidades de cuidados intensivos
Jorge, I. M. F. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Paula, J. D., Bastos, T. C. S., Palma, A. L. D. R., & Borges, A. C. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n2-303 · Cited by 1
Hoy, M. J., & Heitman, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_9 · Cited by 1
Composição química, atividades biológicas e toxicidade in vitro do óleo de licuri
Braga, G., Vaz, U. P., Carpanez, A. G., Grazul, R. M., de Assis, P. M., García, A., Brandão, M. A. F., & Raposo, N. R. B. (2023) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/oleo-de-licuri · Cited by 1
Cowen, A., Yiu, B., Fallah, S., Meyer, K. J., Puumala, E., Lee, Y., Zubyk, H. L., Robbins, N., Nodwell, J. R., MacAlpine, J., et al. (2025) · mSphere · doi:10.1128/msphere.00098-25 · Cited by 1
Self-citationCompound Z247611722 Exhibits Antifungal Activity by Inhibiting Serine Palmitoyltransferase
Nysten, J. V., Eynde, W. V., Lee, Y., Vanhoffelen, E., Desiderati, G., Win, T. V., Velde, G. V., Voet, A. R. D., Robbins, N., Cowen, L. E., et al. (2026) · Nature Communications · doi:10.21203/rs.3.rs-6810020/v1 · Cited by 1
Self-citationD’Ambrosio, K., Fiore, A. D., Alterio, V., Buonanno, M., Vivenzio, V. M., Monti, S. M., Simone, G. D., & Langella, E. (2025) · The Enzymes · doi:10.1016/bs.enz.2025.07.003 · Cited by 1
Effects of novel organoantimony compounds on the fungal pathogen Cryptococcus neoformans
Cotton, K., Lieberman, J. A., Gerasimchuk, N., & Wozniak, K. L. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002058 · Cited by 1
Gong, X., Ge, X., Qin, Q., Wang, B., Wang, L., Jin, C., & Fang, W. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00122-25 · Cited by 1
Epidemiology and Management of Antifungal-Resistant Bloodstream Infections in Healthcare Settings
Sayyouh, O. (2025) · Infectious diseases · doi:10.5772/intechopen.1012710 · Cited by 1
Sun, L., Luo, Z., Zou, X., Sun, C., Peng, F., Peng, C., & Zhou, Q. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04890-3 · Cited by 1
Coenzyme A metabolism in fungi: a new frontier in antifungal therapy
Choi, J., Chiang, A., & Mamoun, C. B. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00307-25 · Cited by 1
Nysten, J. V., Campenhout, L. V., Vanhoffelen, E., Velde, G. V., & Dijck, P. V. (2026) · Scientific Reports · doi:10.1038/s41598-026-48741-7 · Cited by 1
Reddy, S., Paul, S., Rudramurthy, S. M., Kaur, H., & Ghosh, A. K. (2026) · Mycopathologia · doi:10.1007/s11046-026-01074-5 · Cited by 1
Jayasekara, L. A. C. B., Watchaputi, K., Euanorasetr, J., Poomputsa, K., Butkinaree, C., & Soontorngun, N. (2026) · FEMS Yeast Research · doi:10.1093/femsyr/foag021 · Cited by 1
The Fungus Among Us: Why the Treatment of Fungal Infections Is So Problematic
Haupt, K., Wagner, L., Häder, A., & Vylkova, S. (2020) · Frontiers for Young Minds · doi:10.3389/frym.2020.557533 · Cited by 1
de Carvalho, R. D. P., Pavanello, L., dos Santos, V. A. B., de Almeida, T. B., Silva, D. R., Rosa, C. S., Rosa, F. S., de Moraes, H. A. B., & Cogo, K. (2022) · ARCHIVES OF HEALTH INVESTIGATION · doi:10.21270/archi.v11i4.5800 · Cited by 1
Brandolt, T. M., Klafke, G. B., Ramos, D. F., Halicki, P. C. B., Vicenti, J. R. D. M., Pereira, W. A., Poester, V. R., Sanchotene, K. O., & Xavier, M. O. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e20152 · Cited by 1
Savić, K. J., Djokić, L., Stankovic, N., Morić, I., Pavlovic, B., Šenerović, L., Aydogan, C., & Pavić, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105617 · Cited by 1
Natural and Synthetic Peptides to Control Drug-resistant Pathogens
de Sousa, F. J. F., Costa, I. R. S., Cavalcante, F. L. P., SILVA, A., Brito, D. M. D. S., da Silva, J. Y. G., Silva, J. J. L., de Almeida, C. B., Mesquita, F. P., & Souza, P. F. N. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230621121330 · Cited by 1
An Overview on Antifungal Drug Therapy
More, M., Jadhav, P. D., Bhongale, A., Velhal, A. B., Redasani, V., & Naikawadi, N. D. (2023) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v11i3.1270 · Cited by 1
Sharma, G., & Sharma, R. K. (2024) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20247003180 · Cited by 1
Role of nanotechnology derived natural products as potential therapeutics against infectious disease
Verma, K., Nehal, N., Chaturvedi, A., & Sharma, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13337-4.00008-2 · Cited by 1
Ali, S. H., Osmaniye, D., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2024) · ACS Omega · doi:10.1021/acsomega.3c07879 · Cited by 1
Chattha, G. M., Chattha, M. A., Beys‐da‐Silva, W. O., & Santi, L. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107125 · Cited by 1
Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1
A atividade imunomoduladora de ArtinM sobre o curso da infecção por Cryptococcus gattii
Brito, P. K. M. O. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-30052019-151910 · Cited by 1
Drugs from bugs in creatures of the sea
Cowen, L. E. (2020) · Science · doi:10.1126/science.abf1675 · Cited by 1
Self-citationMetabolic sensing tips the balance of drug tolerance in fungal meningitis
Mottola, A., Hartl, J., Ralser, M., & Berman, J. G. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01595-5 · Cited by 1
Conjugation Based CRISPR Antifungals (COBRA)Preprint
Nasrollahi, V., & Karas, B. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.06.692781 · Cited by 1
de Santana, D. C. N. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
РАН, Ф. И. О. Г. И. Н. И. В., Slezina, M. P., Istomina, E. A., РАН, Ф. И. О. Г. И. Н. И. В., Odintsova, T. I., & РАН, Ф. И. О. Г. И. Н. И. В. (2019) · Sel skokhozyaistvennaya Biologiya · doi:10.15389/agrobiology.2019.1.169rus
Targeting Casein Kinases in the Fungal Pathogen Candida albicans
Hyde, S. (2020) · TSpace (University of Toronto)
Analytical approach to “in vitro” studies of the chinocandin Caspofungin
Uribe, B. (2020) · theses.fr (ABES) · doi:10.70675/797f98b7ze0d0z44b1zbaa1zd977b1dcd4c3
Kaushik, M., Sharma, A., Gupta, S., & Gulati, P. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080056123020008
Triple-Action Antifungal Topicals, Microbiologist's Alarm
Éric, K. I. (2023) · Asian Journal of Biology · doi:10.9734/ajob/2023/v19i1357
Antifungal Potential of Propolis Extract Against Candida Albicans: Literature Review
Soerjanto, O. M., Endraswari, P. D., & Purba, A. K. R. (2023) · International Journal of Science and Society · doi:10.54783/ijsoc.v5i5.963
Banerjee, D., Gangwar, P., & Fateh, M. V. (2024) · Journal Of Advanced Zoology · doi:10.53555/jaz.v45i3.4389
Candida albicans - Epidemiology and Treatment
Behzadi, P. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1001505
Itoh, K., Tsutani, H., Mitsuke, Y., & Iwasaki, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1452497
Waykar, R. G., & Kumarapillai, S. (2025) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/zm6uc
Bohner, F. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12031
TARGETING IRON ACQUISITION MECHANISMS OF INVASIVE FUNGAL INFECTIONS: OLD AND NEW INSIGHTS
Iași, U., MARIAN, M., Mareș, M., & Iași, U. (2024) · Lucrări Ştiinţifice - Medicină Veterinară, Universitatea de Ştiinţe Agricole şi Medicină Veterinară "Ion Ionescu de la Brad" Iaşi · doi:10.61900/spjvs.2024.03.05
Kаyukova, L. A., Сейдахметова, Р. Б., Duisenali, A., Yerlanuly, A., & Sartoyeva, A. (2025) · Chemical Journal of Kazakhstan · doi:10.51580/2025-1.2710-1185.13
Acharjee, S., & Hyland, E. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.02.662741
Ahmad, R. A., Sulaiman, S. A., & Nuradeen, A. S. (2025) · International Journal of Advanced Research · doi:10.21474/ijar01/21214
Ayala, K. E., Baum, S., Thrikawala, S. U., Goins, M. L., Anderson, M., Davis, C., Pollock, H., & Rosowski, E. E. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2539639
Ponde, N. O., Cook, M. E., Mehta, I., Dey, I., Yamamoto, K., Taylor, T. C., Coleman, B. M., Vyas, S., Bechara, R., Das, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.07.674635
Biçer, M., Serçinoğlu, O., & Okur, T. (2025) · Celal Bayar Üniversitesi Fen Bilimleri Dergisi · doi:10.18466/cbayarfbe.1593863
The Role of the Immune System Against Neuromycotic Infections
Vicente, V., Tostes, A. F., & Shieh, I. C. (2025) · Fungal biology · doi:10.1007/978-3-032-06014-3_7
Antifungal drugs, resistance towards them, and their mechanisms
Sambre, S., Chavan, P., Girse, H., & Gajbhiye, K. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29273-6.00002-3
Ortega, N. C. (2024) · SiB Colombia - GBIF Colombia · doi:10.15472/kd1kak
Waykar, R. G., & Kumarapillai, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5093812
New strategies for combating Candida biofilms adhered to venous access devices
Reginatto, P. (2019) · Lume (Universidade Federal do Rio Grande do Sul)
Aguiar, A. L. R. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ferreira, T. L. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bédard, C. (2023) · Corpus Université Laval (Université Laval)
Xue, A. (2022) · TSpace (University of Toronto)
Validation of candidate genes for drug resistance in model organism Saccharomyces cerevisiae
Škofljanc, N. (2023) · Repository of the University of Ljubljana (University of Ljubljana)
Sánchez Quiroz, P. L. (2021) · Universidad de Chile
Dahal, G. P. (2018) · OhioLink ETD Center (Ohio Library and Information Network)
Photobiomodulation of fungi by low-power lasers: a systematic review
Nunes, B. D. M., Farias, T. G., Dantas, F. J. D. S., de Paoli, F., & da Fonseca, A. D. S. (2025) · Laser Physics Letters · doi:10.1088/1612-202x/ae2df3
Domingos, J. M. L. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Characterization of the Broad-Spectrum Antifungal NPD8193 as an Inhibitor of Cellular Trafficking
Lim, W. S. (. (2025) · TSpace (University of Toronto)
Functional Genomic Analysis of Protein Kinases in the Human Fungal Pathogen Candida albicans
Lee, Y. (2023) · TSpace (University of Toronto)
Development of Fungal-selective Molecules and Strategies to Target Hsp90
LeBlanc, E. V. (2020) · TSpace (University of Toronto)
Thompson, K. M. (2025) · TSpace (University of Toronto)
État des connaissances sur les mycoses cutanées du chat, autres que les dermatophytoses
Mazeran, B. (2025) · HAL
The oxidative stress response in the opportunistic filamentous fungus Scedosporium apiospermum
Yaakoub, H. (2021) · theses.fr (ABES) · doi:10.70675/685945f0z7c01z488bzac4cz4eb5e63b17c3
Functional and structural studies of drug efflux by Cdr1p, an ABC transporter of Candida fungi
Pata, J. (2023) · theses.fr (ABES) · doi:10.70675/6adbc74dzad88z4878zbfc2z4a16da9e0458
Kharrat, O. (2025) · theses.fr (ABES) · doi:10.70675/c47e5b02ze7d4z4d9cz9fd6z03e321b9669f
Sahin, K., AKTURA, S. Ş., Bahçeci, İ., Altuntaş, D. B., & Otegeceli, M. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094127
Wu, S., Huang, Q., Luo, Y., Jiang, J., & Fu, C. (2026) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2026.113351
Hartl, J., Lehmann, A. D., Wahl, F., & Ralser, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731662
Vardanyan, R., & Vardanyan, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-51186-8.00012-9
Veerkar, P., Patel, J., Vengurlekar, S., & Jain, S. K. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.70s.33
Yin, Y., Zhao, Y., Zhao, M., Zhang, L., Li, R., & Liu, L. (2026) · Journal of Fungi · doi:10.3390/jof12080565
Metadata
- Authors
- Robbins, N., Wright, G. D., & Cowen, L. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- University of Toronto (CA)
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2016-10-14
- Volume
- 4
- Issue
- 5
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2532305189
- Cited by
- 271
- References
- 182
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 22 · 2021: 29 · 2020: 27 · 2019: 17 · 2018: 10 · 2017: 5
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, invasive fungal infections, antifungal resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, antifungal drug development, antifungal drug targets, combination antifungal therapy, drug toxicity, immunocompromised patients, novel antifungal agents
- MeSH terms
- Animals, Antifungal Agents, Fungi, Humans, Mycoses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.